BIOLOGICAL RELEVANCE. ENGINEERED PRECISION.
Applied StemCell is a leading biotechnology research company dedicated to advancing genetic and cell-based medicine. Through its proprietary TARGATT™ and S-SELeCT™ technologies, Applied StemCell is at the forefront of innovation, enabling safe and scalable site-specific integration of large payloads with reliable gene expression. This facilitates the development of next-generation therapies, both ex vivo and in vivo. The primary address of Applied StemCell is 521 Cottonwood Drive, Suite 111, Milpitas, CA 95035, US.
With deep expertise in iPSCs and cell line engineering, Applied StemCell provides comprehensive solutions that accelerate innovation across academia and biopharma. The company's strong IP foundation and cutting-edge technologies empower partners to move from concept to clinic with precision, scalability, and confidence. Applied StemCell remains committed to pioneering advancements in biotechnology.
Applied StemCell continues to expand its capabilities and impact in the biotechnology sector, focusing on delivering high-quality solutions and fostering collaborations that drive scientific breakthroughs. We invite the manager of Applied StemCell to create a customized and exclusive company showcase and product listing on our platform to further enhance visibility and commercial opportunities.
Compare Applied StemCell with 3 companies in Biotechnology-Research
| Comparison Field |
Applied StemCellMain Company |
Poseida Therapeutics...View Profile |
AldevronView Profile |
Advanced Therapies,...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 1998 | 2004 |
|
Company Size
|
— | 201-500 | 1,001-5,000 | 501-1,000 |
|
City
|
Milpitas, CA | San Diego, California | Fargo, North Dakota | Philadelphia, Pennsylvania |
|
Country
|
United States | United States | United States | United States |
|
Skills & Keywords
Comparing with main company
|
21 Total Skills
Genome Engineering
iPSCs
Cell Line Development
Gene Therapy
Bioproduction
CRISPR/Cas9
Biotechnology
HEK293
CHO cells
GMP iPSC
iPSC Generation
iPSC-CAR-NK
Cell Banking
Safe Harbor Locus
Antibody Library Technology
Biological Drugs
iPSC Disease Modeling
Cell Therapy
iPSC Differentiation
Bioservices
Cell Manufacturing
|
21 Total
1 Common
20 Unique
Match
5%
Common Skills:
Biotechnology
Unique Skills:
Adoptive Cell Therapy
Allogeneic
CAR-T cells
Cas-CLOVER™
Cytotoxic T Lymphocytes
Gene Editing
+14
|
7 Total
7 Unique
Unique Skills:
cGMP
Gene Editing
GMP-Source
Messenger RNA (mRNA)
Plasmid DNA
Recombinant Proteins
+1
|
30 Total
1 Common
29 Unique
Match
5%
Common Skills:
Biotechnology
Unique Skills:
AAV
Adventitious Agent Testing
Allogeneic
Analytical Development
Antibody Drug Conjugate
Autologous
+23
|
Other organizations in the same industry
This company is also known as